Lung Diseases: all 3,319 studies

Page 8 of 34. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.

• Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD PatientsCompletedNCT01533922Phase 3Results posted
• Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01529632Phase 3Results posted
• Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01513460Phase 3Results posted
• The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01490125Phase 3Results posted
• Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory InfectionCompletedNCT01483625Phase 4Results posted
• Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseTerminatedNCT01473758Phase 2Results posted
• Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01471171Phase 3Results posted
• Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose CombinationCompletedNCT01462942Phase 3Results posted
• Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01462929Phase 3Results posted
• A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary DiseaseCompletedNCT01448850Phase 2Results posted
• Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)CompletedNCT01443845Phase 4Results posted
• Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary FibrosisCompletedNCT01442779Phase 2Results posted
• Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT01437878Phase 2Results posted
• Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01437540Phase 3Results posted
• Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01437397Phase 3Results posted
• Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431287Phase 3Results posted
• Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431274Phase 3Results posted
• Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN)CompletedNCT01426581Not applicableResults posted
• Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 StudyCompletedNCT01426009Phase 2Results posted
• Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) PopulationCompletedNCT01425814Phase 2Results posted
• A Clinical Trial for CTD-ILD TreatmentTerminatedNCT01424033Phase 2/3Results posted
• Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01415518Phase 4Results posted
• Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01398943Not applicableResults posted
• Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01397890Phase 4Results posted
• A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPDCompletedNCT01395888Phase 3Results posted
• Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary DiseaseCompletedNCT01391559Not applicableResults posted
• Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle WastingTerminatedNCT01388920Phase 2Results posted
• ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical PracticeCompletedNCT01388166Results posted
• Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPDCompletedNCT01387230Phase 3Results posted
• Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary DiseaseCompletedNCT01387178Results posted
• Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed PatientsCompletedNCT01385696Phase 3Results posted
• Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01381471Results posted
• Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing ExacerbationsCompletedNCT01381406Results posted
• Effects of Vibration Training on Exercise Capacity in COPD-patientsCompletedNCT01380639Not applicableResults posted
• Effect of Ketoconazole on BreathlessnessCompletedNCT01378520Phase 4Results posted
• Long-term Safety Study for GSK573719/GW642444 in JapaneseCompletedNCT01376388Phase 3Results posted
• A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPDCompletedNCT01376245Phase 3Results posted
• Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01372462Not applicableResults posted
• A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01372410Phase 2Results posted
• Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01355978Not applicableResults posted
• PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01350128Phase 2Results posted
• PT003 MDI Cardiovascular Safety StudyCompletedNCT01349803Phase 2Results posted
• In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory InsufficiencyCompletedNCT01347931Not applicableResults posted
• A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))CompletedNCT01342913Phase 3Results posted
• Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety PopulationCompletedNCT01337336Results posted
• A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPDCompletedNCT01336608Phase 3Results posted
• Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance TherapiesCompletedNCT01332461Results posted
• Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an ExacerbationCompletedNCT01332097Phase 2Results posted
• Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01331694Results posted
• Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)CompletedNCT01329029Phase 4Results posted
• An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study ACompletedNCT01328444Phase 3Results posted
• An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study BCompletedNCT01323660Phase 3Results posted
• Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01323634Phase 3Results posted
• Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01323621Phase 3Results posted
• A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01322594Phase 1Results posted
• 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseCompletedNCT01316913Phase 3Results posted
• 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseCompletedNCT01316900Phase 3Results posted
• A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01316887Phase 3Results posted
• QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01315249Phase 3Results posted
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01313676Phase 3Results posted
• A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPDCompletedNCT01313650Phase 3Results posted
• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDCompletedNCT01313637Phase 3Results posted
• Reliability, Sensitivity and Validity of the 6 Minute Step Test in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01298661Not applicableResults posted
• Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)CompletedNCT01293006Phase 1Results posted
• Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01285492Phase 3Results posted
• Effectiveness of Incorporating Tai Chi in Pulmonary Rehabilitation Program for Chronic Obstructive Pulmonary Disease Patients in Primary Health CareCompletedNCT01259245Not applicableResults posted
• GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic DiseasesTerminatedNCT01257802Phase 3Results posted
• Evaluation of the Effect of AZD5069 in Patients With BronchiectasisCompletedNCT01255592Phase 2Results posted
• A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01233232Phase 2Results posted
• A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01227278Phase 2Results posted
• Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT01218126Phase 2Results posted
• AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)CompletedNCT01215279Phase 2Results posted
• High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)CompletedNCT01214200Not applicableResults posted
• The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01205269Phase 2Results posted
• A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01202188Phase 3Results posted
• A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPDCompletedNCT01192191Phase 3Results posted
• DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations?CompletedNCT01184118Not applicableResults posted
• Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01154127Phase 3Results posted
• Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01153321Phase 2Results posted
• Evaluating Forced Oscillation Technique (FOT) in Abolishing Flow LimitationCompletedNCT01151618Not applicableResults posted
• Adjusting to Chronic Conditions Using Education, Support, and SkillsCompletedNCT01149772Not applicableResults posted
• Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseCompletedNCT01126437Phase 3Results posted
• Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01124422Phase 4Results posted
• A Study to Assess the Long-term Safety of QVA149CompletedNCT01120717Phase 3Results posted
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) ExacerbationsCompletedNCT01120691Phase 3Results posted
• Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT01120093Phase 2Results posted
• Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01119950Phase 2Results posted
• Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsCompletedNCT01119937Phase 3Results posted
• Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary DiseaseCompletedNCT01110252Not applicableResults posted
• Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization StudyCompletedNCT01110200Phase 4Results posted
• A Comprehensive Care Programme for Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01108835Not applicableResults posted
• Stepping up to Health - for Veterans With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01102777Not applicableResults posted
• Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01089127Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01085045Phase 2Results posted
• Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol FumarateCompletedNCT01078623Phase 2Results posted
• 12-week Efficacy of IndacaterolCompletedNCT01072448Phase 3Results posted
• Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary DiseaseCompletedNCT01072396Phase 4Results posted
• A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to PlaceboCompletedNCT01072149Phase 3Results posted
• A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in JapanCompletedNCT01070784Phase 3Results posted
• Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01069289Phase 3Results posted

← Lung Diseases overview